Lean NAFLD: A not so benign condition?-Reference-Cited by-同舟云学术

Lean NAFLD: A not so benign condition?

Published:2018-01 Issue:1 Volume:2 Page:5-8
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

VanWagner Lisa B.¹²^ORCID,Armstrong Matthew J.³⁴

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of MedicineNorthwestern University Feinberg School of MedicineChicago IL

2. Department of Preventive MedicineNorthwestern University Feinberg School of MedicineChicago IL

3. Liver and Transplant UnitQueen Elizabeth University Hospital BirminghamBirmingham United Kingdom

4. National Institute for Health Research, Birmingham Biomedical Research Centre and Centre for Liver ResearchUniversity of BirminghamBirmingham United Kingdom

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1143

Reference13 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

3. New trends on obesity and NAFLD in Asia

4. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy

5. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MASLD- Global prevalence, pathophysiological processes and management pathways- tackling a complex problem;Gastroenterology & Hepatology: Open access;2024-07-25

2. Association between alanine aminotransferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a retrospective cohort study in lean Chinese individuals;Scientific Reports;2024-03-13

3. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1);eLife;2023-08-15

4. Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions;Cureus;2023-08-02

5. Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases;eBioMedicine;2023-08